{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:36:26Z","timestamp":1787020586994,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,13]],"date-time":"2022-12-13T00:00:00Z","timestamp":1670889600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A disintegrin and metalloproteinase with thrombospondin-like motifs (ADAMTS) is involved in inflammation and fertility in women with polycystic ovary syndrome (PCOS). This study aims to assess the role of ADAMTS level in the outcomes of in vitro fertilization and embryo transfer (IVF-ET) in women with PCOS, using a meta-analytic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched Web of Science, PubMed, EmBase, and the Cochrane library to identify potentially eligible studies from inception until December 2021. Study assess the role of ADAMTS levels in patients with PCOS was eligible in this study. The pooled effect estimates for the association between ADAMTS level and IVF-ET outcomes were calculated using the random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Five studies involving a total of 181 patients, were selected for final analysis. We noted that ADAMTS-1 levels were positively correlated to oocyte maturity (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.67;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004), oocyte recovery (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.74;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006), and fertilization (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.46;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.041) rates. Moreover, ADAMTS-4 levels were positively correlated to oocyte recovery (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.91;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001), and fertilization (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.85;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.017) rates. Furthermore, downregulation of ADAMTS-1, ADAMTS-4, ADAMTS-5, and ADAMTS-9 was associated with elevated follicle puncture (ADAMTS-1: weighted mean difference [WMD], 7.24,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-4: WMD, 7.20,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-5: WMD, 7.20,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-9: WMD, 6.38,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), oocytes retrieval (ADAMTS-1: WMD, 1.61,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-4: WMD, 3.63,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004; ADAMTS-5: WMD, 3.63,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004; ADAMTS-9: WMD, 3.20,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.006), and Germinal vesicle oocytes levels (ADAMTS-1: WMD, 2.89,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-4: WMD, 2.19,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-5: WMD, 2.19,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001; ADAMTS-9: WMD, 2.89,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Finally, the oocytes recovery rate, oocyte maturity rate, fertilization rate, cleavage rate, good-quality embryos rate, blastocyst formation rate, and clinical pregnancy rate were not affected by the downregulation of ADAMTS-1, ADAMTS-4, ADAMTS-5, and ADAMTS-9 (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&gt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study found that the outcomes of IVF-EF in patients with PCOS could be affected by ADAMTS-1 and ADAMTS-4; further large-scale prospective studies should be performed to verify these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12958-022-01035-9","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T23:31:56Z","timestamp":1670887916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of ADAMTS proteoglycanases downregulation with IVF-ET outcomes in patients with polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Yanbin","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiyuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,13]]},"reference":[{"key":"1035_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.rbmo.2017.10.114","volume":"36","author":"X Cai","year":"2018","unstructured":"Cai X, Qiu S, Li L, et al. Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis. Reprod Biomed Online. 2018;36:172\u201380.","journal-title":"Reprod Biomed Online"},{"key":"1035_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Polycystic ovary syndrome. N Engl J Med. 2016;375:54\u201364.","journal-title":"N Engl J Med"},{"key":"1035_CR3","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1093\/humrep\/det469","volume":"29","author":"MP Lauritsen","year":"2014","unstructured":"Lauritsen MP, Bentzen JG, Pinborg A, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod. 2014;29:791\u2013801.","journal-title":"Hum Reprod"},{"key":"1035_CR4","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/GRF.0000000000000593","volume":"64","author":"AE Martini","year":"2021","unstructured":"Martini AE, Healy MW. Polycystic Ovarian Syndrome: Impact on Adult and Fetal Health. Clin Obstet Gynecol. 2021;64:26\u201332.","journal-title":"Clin Obstet Gynecol"},{"key":"1035_CR5","doi-asserted-by":"publisher","first-page":"20490","DOI":"10.1038\/s41598-021-99850-4","volume":"11","author":"NJ Su","year":"2021","unstructured":"Su NJ, Huang CY, Liu J, et al. Association between baseline LH\/FSH and live-birth rate after fresh-embryo transfer in polycystic ovary syndrome women. Sci Rep. 2021;11:20490.","journal-title":"Sci Rep"},{"key":"1035_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14310\/horm.2002.11165","volume":"5","author":"E Diamanti-Kandarakis","year":"2006","unstructured":"Diamanti-Kandarakis E, Piperi C, Argyrakopoulou G, et al. Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens). 2006;5:17\u201334.","journal-title":"Hormones (Athens)"},{"key":"1035_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108717","volume":"107","author":"J Huang","year":"2022","unstructured":"Huang J, Chen P, Xiang Y, et al. Gut microbiota dysbiosis-derived macrophage pyroptosis causes polycystic ovary syndrome via steroidogenesis disturbance and apoptosis of granulosa cells. Int Immunopharmacol. 2022;107: 108717.","journal-title":"Int Immunopharmacol"},{"key":"1035_CR8","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1210\/clinem\/dgab275","volume":"106","author":"I Huang-Doran","year":"2021","unstructured":"Huang-Doran I, Kinzer AB, Jimenez-Linan M, et al. Ovarian Hyperandrogenism and Response to Gonadotropin-releasing Hormone Analogues in Primary Severe Insulin Resistance. J Clin Endocrinol Metab. 2021;106:2367\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"1035_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10815-021-02379-8","volume":"39","author":"N Gleicher","year":"2022","unstructured":"Gleicher N, Darmon SK, Molinari E, et al. Importance of IGF-I levels in IVF: potential relevance for growth hormone (GH) supplementation. J Assist Reprod Genet. 2022;39:409\u201316.","journal-title":"J Assist Reprod Genet"},{"key":"1035_CR10","first-page":"3234","volume":"12","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ouyang X, You S, et al. Effect of human amniotic epithelial cells on ovarian function, fertility and ovarian reserve in primary ovarian insufficiency rats and analysis of underlying mechanisms by mRNA sequencing. Am J Transl Res. 2020;12:3234\u201354.","journal-title":"Am J Transl Res"},{"key":"1035_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37:467\u2013520.","journal-title":"Endocr Rev"},{"key":"1035_CR12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1093\/humupd\/dmv029","volume":"21","author":"S Palomba","year":"2015","unstructured":"Palomba S, de Wilde MA, Falbo A, et al. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21:575\u201392.","journal-title":"Hum Reprod Update"},{"key":"1035_CR13","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","volume":"28","author":"S Palomba","year":"2017","unstructured":"Palomba S, Daolio J, La Sala GB. Oocyte competence in women with polycystic ovary syndrome. Trends Endocrinol Metab. 2017;28:186\u201398.","journal-title":"Trends Endocrinol Metab"},{"key":"1035_CR14","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","volume":"27","author":"S Palomba","year":"2021","unstructured":"Palomba S, Piltonen TT, Giudice LC. Endometrial function in women with polycystic ovary syndrome: a comprehensive review. Hum Reprod Update. 2021;27:584\u2013618.","journal-title":"Hum Reprod Update"},{"key":"1035_CR15","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.fertnstert.2014.11.017","volume":"103","author":"KL Rosewell","year":"2015","unstructured":"Rosewell KL, Al-Alem L, Zakerkish F, McCord L, Akin JW, Chaffin CL, Br\u00e4nnstr\u00f6m M, Curry TE Jr. Induction of proteinases in the human preovulatory follicle of the menstrual cycle by human chorionic gonadotropin. Fertil Steril. 2015;103:826\u201333.","journal-title":"Fertil Steril"},{"key":"1035_CR16","doi-asserted-by":"publisher","first-page":"4689","DOI":"10.1073\/pnas.080073497","volume":"97","author":"RL Robker","year":"2000","unstructured":"Robker RL, Russell DL, Espey LL, et al. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A. 2000;97:4689\u201394.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1035_CR17","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1210\/me.2003-0380","volume":"18","author":"KM Doyle","year":"2004","unstructured":"Doyle KM, Russell DL, Sriraman V, et al. Coordinate transcription of the ADAMTS-1 gene by luteinizing hormone and progesterone receptor. Mol Endocrinol. 2004;18:2463\u201378.","journal-title":"Mol Endocrinol"},{"key":"1035_CR18","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1095\/biolreprod.102.013714","volume":"69","author":"P Madan","year":"2003","unstructured":"Madan P, Bridges PJ, Komar CM, et al. Expression of messenger RNA for ADAMTS subtypes changes in the periovulatory follicle after the gonadotropin surge and during luteal development and regression in cattle. Biol Reprod. 2003;69:1506\u201314.","journal-title":"Biol Reprod"},{"key":"1035_CR19","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1677\/jme.0.0310473","volume":"31","author":"D Boerboom","year":"2003","unstructured":"Boerboom D, Russell DL, Richards JS, et al. Regulation of transcripts encoding ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs-1) and progesterone receptor by human chorionic gonadotropin in equine preovulatory follicles. J Mol Endocrinol. 2003;31:473\u201385.","journal-title":"J Mol Endocrinol"},{"key":"1035_CR20","doi-asserted-by":"publisher","first-page":"4603","DOI":"10.1210\/en.2004-0542","volume":"145","author":"M Shimada","year":"2004","unstructured":"Shimada M, Nishibori M, Yamashita Y, et al. Down-regulated expression of A disintegrin and metalloproteinase with thrombospondin-like repeats-1 by progesterone receptor antagonist is associated with impaired expansion of porcine cumulus-oocyte complexes. Endocrinology. 2004;145:4603\u201314.","journal-title":"Endocrinology"},{"key":"1035_CR21","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1210\/en.2011-1172","volume":"152","author":"MC Peluffo","year":"2011","unstructured":"Peluffo MC, Murphy MJ, Baughman ST, et al. Systematic analysis of protease gene expression in the rhesus macaque ovulatory follicle: metalloproteinase involvement in follicle rupture. Endocrinology. 2011;152:3963\u201374.","journal-title":"Endocrinology"},{"key":"1035_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.bbrc.2005.04.177","volume":"333","author":"S Freimann","year":"2005","unstructured":"Freimann S, Ben-Ami I, Dantes A, et al. Differential expression of genes coding for EGF-like factors and ADAMTS1 following gonadotropin stimulation in normal and transformed human granulosa cells. Biochem Biophys Res Commun. 2005;333:935\u201343.","journal-title":"Biochem Biophys Res Commun"},{"key":"1035_CR23","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1095\/biolreprod.104.038083","volume":"72","author":"JS Richards","year":"2005","unstructured":"Richards JS, Hernandez-Gonzalez I, Gonzalez-Robayna I, et al. Regulated expression of ADAMTS family members in follicles and cumulus oocyte complexes: evidence for specific and redundant patterns during ovulation. Biol Reprod. 2005;72:1241\u201355.","journal-title":"Biol Reprod"},{"key":"1035_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"1035_CR25","unstructured":"Wells G, Shea B, O\u2019Connell D. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa (ON): Ottawa Hospital Research Institute 2009. Available:\u00a0http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.htm."},{"key":"1035_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177\u201388.","journal-title":"Control Clin Trials"},{"key":"1035_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1177\/0272989X05282643","volume":"25","author":"AE Ades","year":"2005","unstructured":"Ades AE, Lu G, Higgins JP. The interpretation of random-effects metaanalysis in decision models. Med Decis Making. 2005;25:646\u201354.","journal-title":"Med Decis Making"},{"key":"1035_CR28","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions 5.0.1","author":"JJ Deeks","year":"2008","unstructured":"Deeks JJ, Higgins JPT, Altman DG. Analyzing data and undertaking meta-analyses. In: Higgins J, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.1. Oxford, UK: The Cochrane Collaboration; 2008."},{"key":"1035_CR29","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557\u201360.","journal-title":"BMJ"},{"key":"1035_CR30","first-page":"15","volume":"47","author":"A Tobias","year":"1999","unstructured":"Tobias A. Assessing the influence of a single study in meta-analysis. Stata Tech Bull. 1999;47:15\u20137.","journal-title":"Stata Tech Bull"},{"key":"1035_CR31","doi-asserted-by":"publisher","first-page":"E1015","DOI":"10.1210\/jc.2013-4177","volume":"99","author":"S Xiao","year":"2014","unstructured":"Xiao S, Li Y, Li T, et al. Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients. J Clin Endocrinol Metab. 2014;99:E1015\u201321.","journal-title":"J Clin Endocrinol Metab"},{"key":"1035_CR32","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10815-017-0913-7","volume":"34","author":"EN Tola","year":"2017","unstructured":"Tola EN, Karatopuk DU, Koroglu N, et al. Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome. J Assist Reprod Genet. 2017;34:811\u20136.","journal-title":"J Assist Reprod Genet"},{"key":"1035_CR33","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00404-018-4967-2","volume":"299","author":"S GohariTaban","year":"2019","unstructured":"GohariTaban S, Amiri I, Soleimani Asl S, et al. Abnormal expressions of ADAMTS-1, ADAMTS-9 and progesterone receptors are associated with lower oocyte maturation in women with polycystic ovary syndrome. Arch Gynecol Obstet. 2019;299:277\u201386.","journal-title":"Arch Gynecol Obstet"},{"key":"1035_CR34","first-page":"3997000000321","volume":"2359","author":"S Gohari Taban","year":"2021","unstructured":"Gohari Taban S, Amiri I, Saidijam M, et al. ADAMTS proteoglycanases downregulation with impaired oocyte quality in PCOS. Arch Endocrinol Metab. 2021;2359:3997000000321.","journal-title":"Arch Endocrinol Metab"},{"key":"1035_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.647522","volume":"9","author":"G Yang","year":"2021","unstructured":"Yang G, Yao G, Xu Z, et al. Expression Level of ADAMTS1 in Granulosa Cells of PCOS Patients Is Related to Granulosa Cell Function, Oocyte Quality, and Embryo Development. Front Cell Dev Biol. 2021;9: 647522.","journal-title":"Front Cell Dev Biol"},{"key":"1035_CR36","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.ydbio.2006.10.012","volume":"300","author":"HM Brown","year":"2006","unstructured":"Brown HM, Dunning KR, Robker RL, et al. Requirement for ADAMTS-1 in extracellular matrix remodeling during ovarian folliculogenesis and lymphangiogenesis. Dev Biol. 2006;300:699\u2013709.","journal-title":"Dev Biol"},{"key":"1035_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.matbio.2004.11.007","volume":"24","author":"Y Wu","year":"2005","unstructured":"Wu Y, Wu J, Lee DY, et al. Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol. 2005;24:3\u201313.","journal-title":"Matrix Biol"},{"key":"1035_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1093\/humrep\/der036","volume":"26","author":"S Wathlet","year":"2011","unstructured":"Wathlet S, Adriaenssens T, Segers I, et al. Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. Hum Reprod. 2011;26:1035\u201351.","journal-title":"Hum Reprod"},{"key":"1035_CR39","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/humrep\/deq049","volume":"25","author":"T Adriaenssens","year":"2010","unstructured":"Adriaenssens T, Wathlet S, Segers I, et al. Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics. Hum Reprod. 2010;25:1259\u201370.","journal-title":"Hum Reprod"},{"key":"1035_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/693746","volume":"2014","author":"K Demircan","year":"2014","unstructured":"Demircan K, Topcu V, Takigawa T, et al. ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury. Biomed Res Int. 2014;2014: 693746.","journal-title":"Biomed Res Int"},{"key":"1035_CR41","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.fertnstert.2012.05.007","volume":"98","author":"S Wathlet","year":"2012","unstructured":"Wathlet S, Adriaenssens T, Segers I, et al. New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil Steril. 2012;98:432\u20139.","journal-title":"Fertil Steril"},{"key":"1035_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.fertnstert.2011.04.033","volume":"96","author":"KM Gebhardt","year":"2011","unstructured":"Gebhardt KM, Feil DK, Dunning KR, et al. Human cumulus cell gene expression as a biomarker of pregnancy outcome after single embryo transfer. Fertil Steril. 2011;96:47\u201352.","journal-title":"Fertil Steril"},{"key":"1035_CR43","doi-asserted-by":"publisher","first-page":"28545","DOI":"10.1038\/srep28545","volume":"6","author":"H Tang","year":"2016","unstructured":"Tang H, Liu Y, Li J, et al. Gene knockout of nuclear progesterone receptor provides insights into the regulation of ovulation by LH signaling in zebrafish. Sci Rep. 2016;6:28545.","journal-title":"Sci Rep"},{"key":"1035_CR44","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/molehr\/gas038","volume":"19","author":"L Guzman","year":"2013","unstructured":"Guzman L, Adriaenssens T, Ortega-Hrepich C, et al. Human antral follicles <6 mm: a comparison between in vivo maturation and in vitro maturation in non-hCG primed cycles using cumulus cell gene expression. Mol Hum Reprod. 2013;19:7\u201316.","journal-title":"Mol Hum Reprod"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-01035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-01035-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-01035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:10:26Z","timestamp":1671210626000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-01035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1035"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-01035-9","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,13]]},"assertion":[{"value":"27 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"169"}}